Radiotherapy News and Research

RSS

Radiation therapy (in North America), or radiotherapy (in the UK and Australia) also called radiation oncology, and sometimes abbreviated to XRT, is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis).

Regular use of aspirin may help some patients survive head and neck cancer

Regular use of aspirin or other nonsteroidal anti-inflammatory drugs may help some patients with head and neck cancer survive the disease, according to a study led by Professor Jennifer Grandis at the University of California, San Francisco.

27 Jan 2019

Regular use of common pain relief medicines improves survival for head and neck cancer patients

Regular use of a common type of medication, such as aspirin and ibuprofen, significantly improves survival for a third or more patients with head and neck cancer, a new study led by UC San Francisco has found.

25 Jan 2019

Researchers reveal important signaling pathway in breast cancer

Researchers at Kanazawa University report in Proceedings of the National Academy of Sciences of the United States of America that a particular signaling pathway in breast-cancer tumors causes cancer cells to divide symmetrically, expanding the tumor. Inhibiting the pathway by drugs could become a strategy for eliminating the cancer cells.

24 Jan 2019

New nuclear medicine method could improve detection of primary and metastatic melanoma

A new nuclear medicine method for detecting malignant melanoma, one of the most aggressive skin cancers, has been successfully tested for the first time in humans and could improve detection of both primary and metastatic melanoma.

18 Jan 2019

FDA-approved drug hampers cancer metastasis in animal model, shows study

For cancer to spread, it needs a hospitable environment in distant organs. This fertile "soil" can provide a home to circulating malignant cells.

16 Jan 2019

MD Anderson Cancer Center and Nanobiotix collaborate to expand clinical development of NBTXR3

The University of Texas MD Anderson Cancer Center and Nanobiotix today announced a large-scale, comprehensive clinical research collaboration to evaluate innovative strategies for treating patients with head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers, with the first trials to be launched in 2019.

7 Jan 2019

MD Anderson Cancer Center and 4D pharma team up to evaluate live biotherapeutic oncology pipeline

The University of Texas MD Anderson Cancer Center and 4D pharma today announced a strategic collaboration to evaluate 4D's live biotherapeutic oncology pipeline across a range of cancer settings.

7 Jan 2019

Interval of time to biochemical failure could be used as surrogate endpoint for prostate cancer

An analysis of the NRG Oncology clinical trial NRG-RTOG 9202 showed that the interval of time to biochemical failure, or the time it takes for previously treated cancer to return as indicated by prostate specific antigen rise, could be used as a surrogate endpoint for locally advanced prostate cancer.

21 Dec 2018

Researchers discover new mechanism behind spread of malignant pleural mesothelioma

Malignant pleural mesothelioma is divided into three subtypes, one of which is particularly aggressive. Researchers from the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have now managed to discover a mechanism that contributes to this aggressive behavior: the tumor cells of this subtype are able to assume special characteristics that promote migration and therefore spread of the cancer.

13 Dec 2018

Nobel Laureates lecture about immune checkpoint therapy for cancer treatment

The Nobel Lectures held by the laureates of the 2018 Nobel Prize in Physiology or Medicine saw Aula Medica at Karolinska Institutet filled to the brink. In addition to 1,000 audience members in the auditorium, people around the world were able to watch the live broadcast when James P. Allison and Tasuku Honjo talked about their research, the results of which have led to the ground-breaking immune checkpoint therapy for cancer treatment.

12 Dec 2018

Slow-growing type of glioma may be vulnerable to immunotherapy, suggests study

Immunotherapy has proved effective in treating a number of cancers, but brain tumors have remained stubbornly resistant.

11 Dec 2018

New artificial intelligence-based system to differentiate between different types of cancer cells

In cancer patients, there can be tremendous variation in the types of cancer cells from one patient to another, even within the same disease. Identification of the particular cell types present can be very useful when choosing the treatment that would be most effective, but the methods of doing this are time-consuming and often hampered by human error and the limits of human sight.

10 Dec 2018

UMGCCC uses Gammapod radiotherapy to treat breast cancer patients

Radiation oncologists at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center are now treating patients with the GammaPod™, a new FDA-cleared radiation therapy for early-stage breast cancer.

6 Dec 2018

Study: Chemotherapy agent did not improve survival in patients with triple-negative breast cancer

Treating patients who had early-stage triple-negative breast cancer with the chemotherapy agent capecitabine after they completed surgery and standard chemotherapy did not significantly improve disease-free or overall survival compared with observation, according to data from the randomized, phase III GEICAM/CIBOMA clinical trial presented at the 2018 San Antonio Breast Cancer Symposium, held Dec. 4-8.

6 Dec 2018

Triple combination cancer immunotherapy improves survival in mouse model of melanoma

Adoptive cell transfer is a promising cancer immunotherapy that involves isolating T cells from cancer patients that are capable of targeting their tumor, selecting the more active T cells and expanding those in the lab, and then transfusing them back into patients.

30 Nov 2018

Promising class of photonic sensors can be used in high-radiation environments

Researchers at the National Institute of Standards and Technology have published landmark test results that suggest a promising class of sensors can be used in high-radiation environments and to advance important medical, industrial and research applications.

28 Nov 2018

Radiotherapy News and Research

Further Reading

Regular use of aspirin may help some patients survive head and neck cancer

Regular use of common pain relief medicines improves survival for head and neck cancer patients

Researchers reveal important signaling pathway in breast cancer

New nuclear medicine method could improve detection of primary and metastatic melanoma

FDA-approved drug hampers cancer metastasis in animal model, shows study

MD Anderson Cancer Center and Nanobiotix collaborate to expand clinical development of NBTXR3

MD Anderson Cancer Center and 4D pharma team up to evaluate live biotherapeutic oncology pipeline

Interval of time to biochemical failure could be used as surrogate endpoint for prostate cancer

Researchers discover new mechanism behind spread of malignant pleural mesothelioma

Nobel Laureates lecture about immune checkpoint therapy for cancer treatment

Slow-growing type of glioma may be vulnerable to immunotherapy, suggests study

New artificial intelligence-based system to differentiate between different types of cancer cells

UMGCCC uses Gammapod radiotherapy to treat breast cancer patients

Study: Chemotherapy agent did not improve survival in patients with triple-negative breast cancer

Triple combination cancer immunotherapy improves survival in mouse model of melanoma

Promising class of photonic sensors can be used in high-radiation environments

Study: Some bowel cancer patients in the UK have to wait more than a year to begin treatment

Survey: Misconceptions about opioid use undermine pain control among Asian cancer patients

LDR brachytherapy for treating early-stage prostate cancer lacks conclusive data

Molecular DNA analysis could facilitate more accurate prognosis, treatment of aggressive brain tumors

Cancer Research - Second Edition eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News